Esunix Oral Bacteriostatic Gel

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Esunix Oral Bacteriostatic Gel
Generic name
CETYLPYRIDINIUM CHLORIDE
Manufacturer
Xiling (Zhenjiang) Medical Technology Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
3f4ee467-8142-8cb7-e063-6394a90aa7f7
SPL ID
45bc8e85-cabf-40fc-e063-6294a90a4427
Version
3
Effective date
2025-12-12
Source export date
2026-09-28
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:38:59
Harmonized routes table
Harmonized routes
DENTAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For oral use only. Do not swallow. Do not use in children under 6 years of age unless directed by a dentist or physician. Avoid contact with eyes. If contact occurs, rinse thoroughly with water. Stop use and ask a doctor if irritation, swelling, or allergic reaction occurs. Keep out of reach of children. If more than used for application is swallowed, get medical help or contact a Poison Control Center right away. Single-use only.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.